Oncology Services:Clinical Trials
Current Clinical Trials
S1007 — A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less
A Prospective Surveillance Study to Promote Optimal Function During Breast Cancer Survivorship -- Patients to be evaluated pre-surgery by Physical Therapy. Call 331-221-6044 with questions.
CALGB 80702 A phase III trial of 6 versus 12 treatments of adjuvant FOLFOX plus celecoxib or placebo for patients with resected stage III colon cancer
ECOG 7208 A Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-Type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy
LUNG, NONSMALL CELL, METASTATIC
E5508 — Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
MDS/ MULTIPLE MYELOMA
E2905 — Randomized Phase II Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide Alone and in Combination with Epoetin Alfa in Subjects with Low or Intermediate-1 Risk MDS and Symptomatic Anemia
Connect MM —Registry for patients with a new diagnosis of multiple myeloma; patients are followed for up to 8 years.
Rssearch Cyberknife Patient Registry - Registry for any patient treated with SBRS or SBS for cancer
Registry for Prostate Cancer Radiosurgery - Registry for any patient treated with SBRS or SBS for prostate cancer
Please contact the Research Nurse Navigator at 331-221-2162 for more details.